Search Results
Biopharma M&A and Strategic Collaboration Insights (Q3'23)
The latest edition of Oppenheimer & Co. Inc.’s Quarterly Biopharma M&A and Strategic Collaboration Insights Report is now available upon request.
Biopharma M&A and Strategic Collaboration Insights (Q2'23)
The latest edition of Oppenheimer & Co. Inc.’s Quarterly Biopharma M&A and Strategic Collaboration Insights Report is now available upon request.
Biopharma M&A and Strategic Collaboration Insights (Q1'23 and FY'22)
The latest edition of Oppenheimer & Co. Inc.’s Quarterly Biopharma M&A and Strategic Collaboration Insights Report is now available upon request.
You Can't Keep a Good Bond Yield Down
Should issuers stay on the sidelines amid the varied rate headwinds, such lower supply scenario could turn out to be a small gift for October Muni returns, with munis possibly outperforming a further sell-off.
With a Debt Ceiling Deal in Hand, Focus is on the Fed
What had previously been overbought and rich areas of the muni market, are now offering better entry points to lock in higher cash flows and potentially stronger portfolio returns should yields demonstrate meaningful contraction
Will April Demand Showers Bring May Performance Flowers?
Admittedly, our forecasts for greater in-flow activity have yet to come to fruition, yet we remain hopeful should volatility normalize and the value of the asset class stays more consistently center stage
What Is a Fed to Do?
As we approach the end of the first quarter of 2023, we find ourselves conceding the realities of broader and deeper market volatility than initially anticipated leading into this year.
Waitin' on a Sunny Day - A Bruce Springsteen Tribute
With elevated absolute yields and cheaper ratios, investors are advised to extend allocations into munis as tax-efficiency and other attributes drive the process. Better technicals could direct ratios back to richer levels and so the window of opportunity to lock in better terms may hit The Wall soon.
To 25 and Beyond?
There is certainly no shortage of deployable cash and once rates stabilize, we should expect to see more consistent inflow activity.